Hexadecylphosphocholine, a new ether lipid analogue. Studies on the 
antineoplastic activity in vitro and in vivo.

Unger, C.; Damenz, W.; Fleer, E.; Kim, D. J.; Breiser, A.; Hilgard, P.; Engel, J.; Nagel, G.; Eibl, H. J.

doi:10.3109/02841868909111249

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

Hexadecylphosphocholine, a new ether lipid analogue. Studies on the antineoplastic activity in vitro and in vivo.

MPS-Authors

/persons/resource/persons203040

Fleer, E.
Department of Membrane Biophysics, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15029

Eibl, H. J.
Department of Membrane Biophysics, MPI for biophysical chemistry, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

2400792.pdf
(出版社版), 567KB

付随資料 (公開)

There is no public supplementary material available

引用

Unger, C., Damenz, W., Fleer, E., Kim, D. J., Breiser, A., Hilgard, P., Engel, J., Nagel, G., & Eibl, H. J. (1989). Hexadecylphosphocholine, a new ether lipid analogue. Studies on the antineoplastic activity in vitro and in vivo. Acta Oncologica, 28(22), 213-217. doi:10.3109/02841868909111249.

引用: https://hdl.handle.net/11858/00-001M-0000-002C-848A-0

要旨

Hexadecylphosphocholine (He-PC) is a new compound synthesized according to the minimal structural requirements deducted from studies with other ether lipids. In vitro studies on He-PC revealed remarkable antineoplastic activity on HL60, U937, Raji and K562 leukemia cell lines. In addition, He-PC, applied orally, showed a superior effect in the treatment of dimethylbenzanthracene-induced rat mammary carcinomas when compared to intravenously administered cyclophosphamide. After oral application He-PC was well absorbed from the intestine and metabolized in the liver by phospholipases C and D. During a 5-week treatment no hematotoxic effects were detected. In a clinical pilot study on breast cancer patients with widespread skin involvement, topically applied He-PC showed skin tumor regressions without local or systemic side effects.